Sofosbuvir: Clinical Trials

11 trials of Sofosbuvir, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

11 completed. 11 Phase 1, 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	11	Completed 11
Phase 2	3	Completed 3

Follow Sofosbuvir: new trials by email Literature Review of Sofosbuvir trials Research Report on Sofosbuvir

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects HEC110114 Tablet, Sofosbuvir Tablet - Chronic Hepatitis C	Phase 1 / Phase 2	Completed	Sunshine Lake Pharma Co., Ltd.	24	2020-07-06	2020-09-10
A Study of the Relative Bioavailability of ASC18 Tablets vs Reference Tablets in Healthy Volunteers ASC18, ravidasvir and sofosbuvir - Healthy	Phase 1	Completed	Ascletis Pharmaceuticals Co., Ltd.	50	2020-03-20	2021-01-11
Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs Elpida®, Dolutegravir, Sofosbuvir - HIV-1-infection, Hepatic Impairment	Phase 1	Completed	Viriom	36	2018-10-01	2022-01-11
A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada) Sofodelevier, Sovaldi (fist dose), Sovaldi (second dose) - Healthy	Phase 1	Completed	Genuine Research Center, Egypt	36	2016-10-01	2019-08-01
A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada) Magicbuvir, Sovaldi (fist dose), Sovaldi (second dose) - Healthy	Phase 1	Completed	Genuine Research Center, Egypt	36	2016-05-01	2016-11-02
A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom) Elbanovir, Sovaldi - Healthy	Phase 1	Completed	Genuine Research Center, Egypt	24	2015-08-01	2015-11-16
A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland) Heterosofir, Sovaldi - Healthy	Phase 1	Completed	Genuine Research Center, Egypt	24	2015-02-01	2015-07-08
Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection Sofosbuvir, Ribavirin, Ledipasvir/Sofosbuvir - HIV-1 Infection, Hepatitis	Phase 1	Completed	Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections	44	2014-05-30	2018-04-27
Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. SOF, EFV/FTC/TDF, EFV - Hepatitis C, HIV	Phase 1 / Phase 2	Completed	Gilead Sciences	52	2012-03-01	2014-10-01
GS-7977 With Ribavirin for Hepatitis C (SPARE) GS7977, RBV - Hepatitis C	Phase 1 / Phase 2	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	60	2011-09-01	2014-09-26
Open-Label Hepatic Impairment Study PSI-352938, PSI-7977 - Hepatitis C	Phase 1	Completed	Gilead Sciences	24	2011-07-01	2012-06-08

Conditions studied

Sponsors

Countries

Top investigators

Results publications

NIH funding